Sentence examples for mcg doses of from inspiring English sources

The study was redesigned to assess the 20 and 50 mcg doses of the Alhydrogel vaccine in a non-masked, dose escalating fashion.

A 400 mcg dose of sublingual misoprostol has high efficacy and few side effects when used with 200 mg mifepristone for medical abortion through 63 days' gestation.

Mice vaccinated using a sub-optimal 100 mcg dose of a pDNA encoding an unmodified primary isolate HIV-16101 env gp160 failed to demonstrate measurable env-specific CMI responses.

A 600 mcg dose of oral misoprostol has been shown safe and effective in preventing PPH [ 1].

Within the literature on misoprostol as adjunct treatment, a total of three cases of high fever ≥ 40.0°C (≥ 104.0°F) have been reported following a 1000 mcg dose of misoprostol (400 mcg sublingually + 400 mcg rectally + 200 mcg orally) [ 4].

HFA MDIs have been shown to produce ICS with a smaller particle size than CFC MDIs[ 27] resulting in 17% of a 200 mcg dose of BUD being respirable[ 15] compared to 48% of a 200 mcg dose of CIC[ 8, 13].

To establish the effectiveness of adding misoprostol to current treatment regimens, a randomized controlled trial was conducted to test a 600 mcg dose of sublingual misoprostol as an adjunct treatment at four hospitals in Karachi, Pakistan.

A randomized controlled trial was conducted in four Karachi hospitals from December 2005 April 200707 to assess the benefit of a 600 mcg dose of misoprostol given sublingually in addition to standard oxytocics for postpartum hemorrhage treatment.

The rate of transient shivering and fever was significantly higher among women receiving misoprostol A 600 mcg dose of misoprostol given sublingually shows promise as an adjunct treatment for PPH and its use should continue to be explored for its life-saving potential in the care of women experiencing PPH.

An 800-mcg dose of buccal misoprostol following mifepristone has been shown to be highly effective in terminating pregnancies through 63 days since the last menstrual period (LMP) (B. Winikoff, I.G.

Neither the subjects nor investigators were blinded once the saline formulation was removed from the trial, because only one formulation was used and because the dose-escalation design required that the safety of the 20 mcg dose be evaluated prior to administration of the 50 mcg dose.